Australia, July 29 -- Rgenta Therapeutics Inc., owns the trademark (2545920) for 'RDRUG' till April 2, 2035.
Status: protected:
Registered/protected
Class: 5 [Small molecule pharmaceutical preparations for use in cell and gene therapy for treating respiratory and infectious diseases and metabolic disorders, and diseases and disorders of the neurological, oncology, cardiovascular, immune, endocrine, gastrointestinal, ophthalmic, dermatologic and hematologic systems.]
Type of Mark: Word
Date of Acceptance: May 20
Registration Advertised: July 28
For further details contact Jessica L. Rothstein GOODWIN PROCTER LLP .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2545920.
Disclaimer: Cur...